产品详情 |
Edit |   |
Product Name | Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera Protein, CF |
Description | Purity >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 94-100 kDa, reducing conditions. MW (theoretical): 73.9 kDa (monomer). The Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera Protein has been validated for the following applications: Bioactivity. |
Size | 50 ug |
Concentration | n/a |
Applications | Bioactivity |
Other Names | CD85 antigen-like family member D, CD85d, CD85d antigen, Ig-like transcript 4, ILT4, ILT-4, ILT4CD85d, Immunoglobulin-like transcript 4, Leukocyte immunoglobulin-like receptor 2, leukocyte immunoglobulin-like receptor subfamily B member 2, leukocyte immunoglobulin-like receptor subfamily B member 2 soluble isoform, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR2, LIR2CD85D, LIR-2subfamily A (with TM domain), member 6, member 2, MIR10, MIR10LILRA6, Monocyte/macrophage immunoglobulin-like receptor 10 |
Gene, Accession, CAS # | LILRB2, Gene ID: 10288, Accession: Q8N423 |
Catalog # | 2078-T4-050 |
Price | |
Order / More Info | Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
Product Specific References | PubMed: 18025130 |
产品资料 |
|
|